Gray BH - Search Results

1

The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.

Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, McBane RD, Kline-Rogers E, White CJ, Gornik HL. Olin JW, et al. Among authors: gray bh. Circulation. 2012 Jun 26;125(25):3182-90. doi: 10.1161/CIRCULATIONAHA.112.091223. Epub 2012 May 21. Circulation. 2012. PMID: 22615343 Free article.

2

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty.

Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. Gray BH, et al. J Vasc Surg. 1997 Jan;25(1):74-83. J Vasc Surg. 1997. PMID: 9013910 Free article.

3

Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease.

Gray BH, Olin JW. Gray BH, et al. Semin Vasc Surg. 1997 Mar;10(1):8-16. Semin Vasc Surg. 1997. PMID: 9068071

4

Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients.

Sullivan TM, Childs MB, Bacharach JM, Gray BH, Piedmonte MR. Sullivan TM, et al. Among authors: gray bh. J Vasc Surg. 1997 May;25(5):829-38; discussion 838-9. doi: 10.1016/s0741-5214(97)70212-x. J Vasc Surg. 1997. PMID: 9152310 Free article.

5

Angioplasty and primary stenting of the subclavian, innominate, and common carotid arteries in 83 patients.

Sullivan TM, Gray BH, Bacharach JM, Perl J 2nd, Childs MB, Modzelewski L, Beven EG. Sullivan TM, et al. Among authors: gray bh. J Vasc Surg. 1998 Dec;28(6):1059-65. doi: 10.1016/s0741-5214(98)70032-1. J Vasc Surg. 1998. PMID: 9845657 Free article.

6

Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.

Ouriel K, Gray B, Clair DG, Olin J. Ouriel K, et al. J Vasc Interv Radiol. 2000 Mar;11(3):295-8. doi: 10.1016/s1051-0443(07)61420-1. J Vasc Interv Radiol. 2000. PMID: 10735422

7

Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure.

Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Gray BH, et al. Vasc Med. 2002;7(4):275-9. doi: 10.1191/1358863x02vm456oa. Vasc Med. 2002. PMID: 12710843

8

Claudication secondary to Perclose use after percutaneous procedures.

Jang JJ, Kim M, Gray B, Bacharach JM, Olin JW. Jang JJ, et al. Catheter Cardiovasc Interv. 2006 May;67(5):687-95. doi: 10.1002/ccd.20646. Catheter Cardiovasc Interv. 2006. PMID: 16586517

9

Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary.

Creager MA, White CJ, Hiatt WR, Criqui MH, Josephs SC, Alberts MJ, Pearce WH, Gray BH, Rocha-Singh KJ; American Heart Association. Creager MA, et al. Among authors: gray bh. Circulation. 2008 Dec 16;118(25):2811-25. doi: 10.1161/CIRCULATIONAHA.108.191170. Circulation. 2008. PMID: 19106402 No abstract available.

10

Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.

Gray BH, Conte MS, Dake MD, Jaff MR, Kandarpa K, Ramee SR, Rundback J, Waksman R; American Heart Association Writing Group 7. Gray BH, et al. Circulation. 2008 Dec 16;118(25):2864-72. doi: 10.1161/CIRCULATIONAHA.108.191177. Circulation. 2008. PMID: 19106409 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page